Key facts
- This page summarizes Habib J. Dable's Form 3 filing for Tyra Biosciences, Inc. (TYRA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Apr 2026, 16:30.
Habib J. Dable - 16 Apr 2026 Form 3 Insider Report for Tyra Biosciences, Inc. (TYRA)
- Reporting relationship
- Director
- Issuer ticker
- TYRA
- Reported as of
- 16 Apr 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Apr 2026, 16:30:03 UTC
- Prior SEC filing
- 05 Feb 2026
- Next SEC filing
- 23 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ali D. Fawaz, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Habib J. Dable filed Form 3 for Tyra Biosciences, Inc. (TYRA) on 20 Apr 2026.
Change
- Previous filing in this sequence was filed on 05 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001690773
Primary reporting owner
Dable Habib J
- Relationship
- Director
- Address
- C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD
- Signature
- /s/ Ali D. Fawaz, Attorney-in-Fact
- Signature date
- 20 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TYRA
holding
No securities are beneficially owned.
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 16 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney